Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cardiol Therapeutics Inc. (CRDL) vs Lifecore Biomedical, Inc. (LFCR)

Cardiol Therapeutics Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. is the larger, with a market value of $202.1M against $162.4M — 1.2× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −37.5%) and the higher return on invested capital (0.00% vs −2.80%). Across the 13 metrics below, Cardiol Therapeutics Inc. leads on 8 and Lifecore Biomedical, Inc. on 5.

Valuation

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 1.32 2.25
P/B 11.32 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 2.73 2.56
Earnings yield (14.62%) (23.10%) (2.99%)
Free cash flow yield (8.77%) (3.21%) 0.00%

Profitability

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 26.86% 53.94%
Operating margin 0.00% (6.89%) 0.00%
Net margin 0.00% (37.54%) 0.00%
Free cash flow margin 0.00% (4.24%) 0.00%
Return on equity (171.13%) 201.15% (0.40%)
Return on assets (124.40%) (19.32%) (3.32%)
Return on invested capital 0.00% (2.80%) 0.00%

Growth

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (10.03%) 10.01%
EPS growth (last fiscal year) 24.32% (439.33%) —
Revenue growth, 5-year CAGR — (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 11.50 0.05
Current ratio 5.55 3.87 2.31
Net debt to EBITDA 0.62 (15.59) 0.85

Dividend

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRDL LFCR Drug Manufacturers Specialty & Generic median
Market cap 202.10m 162.39m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack